4.5 Review

Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study

期刊

CRITICAL REVIEWS IN TOXICOLOGY
卷 44, 期 1, 页码 1-49

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/10408444.2013.835784

关键词

Di(2-ethylhexyl) phthalate (DEHP); human relevancy framework; key events; liver cancer; mode of action; NF-kB; oxidative stress; peroxisome proliferator-activated receptor alpha (PPAR alpha)

资金

  1. Alliance for Risk Assessment (ARA)
  2. American Chemistry Council (ACC) Center for Advancing Risk Assessment
  3. CropLife America
  4. CXR Biosciences
  5. Dow Chemical Company
  6. DuPont
  7. Hamner Institute for Health
  8. Indiana University Department of Environmental Health
  9. Society for Risk Analysis (SRA)
  10. Society of Toxicology (SOT)
  11. 3M Company
  12. Toxicology Excellence for Risk Assessment (TERA)
  13. U.S. EPA National Health and Environmental Effects Research Laboratory (NHEERL)
  14. U.S. EPA Office of Chemical Safety and Pollution Prevention (OCSPP)
  15. U.S. EPA Office of Water (OW)
  16. TERA

向作者/读者索取更多资源

Several therapeutic agents and industrial chemicals induce liver tumors in rodents through the activation of the peroxisome proliferator-activated receptor alpha (PPAR alpha). The cellular and molecular events by which PPAR alpha activators induce rodent hepatocarcinogenesis has been extensively studied and elucidated. This review summarizes the weight of evidence relevant to the hypothesized mode of action (MOA) for PPAR alpha activator-induced rodent hepatocarcinogenesis and identifies gaps in our knowledge of this MOA. Chemical-specific and mechanistic data support concordance of temporal and dose-response relationships for the key events associated with many PPAR alpha activators including a phthalate ester plasticizer di(2-ethylhexyl) phthalate (DEHP) and the drug gemfibrozil. While biologically plausible in humans, the hypothesized key events in the rodent MOA, for PPAR alpha activators, are unlikely to induce liver tumors in humans because of toxicodynamic and biological differences in responses. This conclusion is based on minimal or no effects observed on growth pathways, hepatocellular proliferation and liver tumors in humans and/or species (including hamsters, guinea pigs and cynomolgous monkeys) that are more appropriate human surrogates than mice and rats at overlapping dose levels. Overall, the panel concluded that significant quantitative differences in PPAR alpha activator-induced effects related to liver cancer formation exist between rodents and humans. On the basis of these quantitative differences, most of the workgroup felt that the rodent MOA is not relevant to humans'' with the remaining members concluding that the MOA is unlikely to be relevant to humans''. The two groups differed in their level of confidence based on perceived limitations of the quantitative and mechanistic knowledge of the species differences, which for some panel members strongly supports but cannot preclude the absence of effects under unlikely exposure scenarios.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据